The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and success in preventing SHIV infection following their passive administration, possess increased the chance that immunotherapeutic strategies could be adopted to avoid and treat HIV-1 infection. rhesus macaques after multiple shots, VRC01, 10-1074 and NIH45-46G54W elicit high titer anti-idiotypic antibodies carrying out a second… Continue reading The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1,